A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis-Reference-Cited by-同舟云学术

A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis

Published:2022-07 Issue:1 Volume:87 Page:95-102
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Zhang Chunlei,Yan Kexiang,Diao Qingchun,Guo Qing,Jin Hongzhong,Yang Sen,Chen Xiang,Lei Tiechi,Wu Jianhua,Yu Hong,Zheng Min,Gao Xinghua,Sinclair Rodney,Zhu Yi,Xu Qian,Xu Jinhua

Funder

Jiangsu Hengrui Medicine Co Ltd

Publisher

Elsevier BV

Subject

Dermatology

Reference20 articles.

1. A systematic review of worldwide epidemiology of psoriasis;Michalek;J Eur Acad Dermatol Venereol,2017

2. Psoriasis;Boehncke;Lancet,2015

3. Psoriasis causes as much disability as other major medical diseases;Rapp;J Am Acad Dermatol,1999

4. A knowledgebase resource for interleukin-17 family mediated signaling;Sharma;J Cell Commun Signal,2015

5. A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis;Campa;Dermatol Ther (Heidelb),2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in psoriasis research: From pathogenesis to therapeutics;Life Sciences;2024-10

2. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05

3. An Experimental Study on the Evaluation of Boerhavia Diffusa in the Treatment of Psoriasis in Albino Mice;Oriental Journal Of Chemistry;2024-04-30

4. Effect of Al₂O₃ Nanoparticle on the characteristic Parameters of PVDF-co-HFP Based Mg²⁺ Conducting Polymer Electrolyte Membranes;ORIENT J CHEM;2024

5. The changing landscape of thyroid eye disease: current clinical advances and future outlook;Eye;2024-02-19